Advertisement

Topics

Haematology Rapid Tests Point of Care POC Medical Devices Pipeline Assessment, 2017 [Report Updated: 01082017] Prices from USD $4000

09:50 EDT 2 Aug 2017 | BioPortfolio Report Blog

Haematology Rapid Tests Point of Care POC Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, Haematology Rapid Tests Point of Care POC Medical Devices Pipeline Assessment, 2017" provides an overview of Haematology Rapid Tests Point of Care POC currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Haematology Rapid Tests Point of Care POC pipeline products.

This report is prepared using data sourced from inhouse databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Haematology Rapid Tests Point of Care POC under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Haematology Rapid Tests Point of Care POC and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to buy

The report enables you to
Formulate significant competitor information, analysis, and insights to improve RD strategies
Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
Identify and understand important and diverse types of Haematology Rapid Tests Point of Care POC under development
Develop marketentry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Indepth analysis of the product's current stage of development, territory and estimated launch date

Original Article: Haematology Rapid Tests Point of Care POC Medical Devices Pipeline Assessment, 2017 [Report Updated: 01082017] Prices from USD $4000

NEXT ARTICLE

More From BioPortfolio on "Haematology Rapid Tests Point of Care POC Medical Devices Pipeline Assessment, 2017 [Report Updated: 01082017] Prices from USD $4000"

Quick Search
Advertisement
 

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...